XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity
6 Months Ended
Jun. 30, 2021
Stockholders Equity Note [Abstract]  
Shareholders' Equity

NOTE 15 – Shareholders’ Equity

Share count and par value data related to shareholders’ equity are as follows:

 

 

 

As of

 

 

 

June 30,

 

 

December 31,

 

 

 

2021

 

 

2020

 

Preferred Stock

 

 

 

 

 

 

 

 

Par value per share

 

No par value

 

 

No par value

 

Shares authorized

 

 

25,000,000

 

 

 

25,000,000

 

Shares outstanding

 

 

 

 

 

 

Common Stock

 

 

 

 

 

 

 

 

Par value per share

 

No par value

 

 

No par value

 

Shares authorized

 

 

75,000,000

 

 

 

75,000,000

 

Shares issued

 

 

57,235,379

 

 

 

57,076,410

 

Shares outstanding

 

 

32,435,756

 

 

 

32,276,787

 

Treasury stock

 

 

 

 

 

 

 

 

Shares held

 

 

24,799,623

 

 

 

24,799,623

 

 

On May 13, 2021, the Board of Directors approved a new share repurchase program that authorizes the Company to repurchase up to $50,000 of the Company’s common stock. The repurchase program has no set expiration date and replaces the repurchase program approved by the Board of Directors on February 7, 2019.  During the six months ended June 30, 2021, no shares of common stock were repurchased. During the six months ended June 30, 2020, 342,731 shares of common stock were repurchased for $8,080. Approximately $50,000 is available for future purchases.

A roll-forward of common shares outstanding is as follows:

 

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2021

 

 

2020

 

Balance at the beginning of the year

 

 

32,276,787

 

 

 

32,472,406

 

Repurchases

 

 

 

 

 

(342,731

)

Restricted share issuances

 

 

158,969

 

 

 

137,632

 

Balance at the end of the period

 

 

32,435,756

 

 

 

32,267,307

 

 

 

Certain potentially dilutive restricted stock units are excluded from diluted earnings per share because they are anti-dilutive. The number of outstanding awards that were anti-dilutive for the three months ended June 30, 2021 and 2020 were 93 and 84,720, respectively. The number of outstanding awards that were anti-dilutive for the six months ended June 30, 2021 and 2020 were 46,810 and 61,780, respectively.